Cargando…

Editorial: Emerging Mechanisms in Purinergic Signaling: From Cell Biology to Therapeutic Perspectives

Detalles Bibliográficos
Autores principales:	Gomez-Villafuertes, Rosa, Adinolfi, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358636/ https://www.ncbi.nlm.nih.gov/pubmed/32733252 http://dx.doi.org/10.3389/fphar.2020.01022

Ejemplares similares

Editorial: Purinergic signaling and neuroinflammation
por: Assmann, Charles Elias, et al.
Publicado: (2022)

Purinergic Signalling: Therapeutic Developments
por: Burnstock, Geoffrey
Publicado: (2017)

Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics
por: Jiang, Lin-Hua, et al.
Publicado: (2021)

Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019)

Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
por: Fonseca, Begoña, et al.
Publicado: (2017)

Contribution of purinergic receptors to spinal cord injury repair: stem cell-based neuroregeneration
por: Gomez-Villafuertes, Rosa
Publicado: (2016)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
por: Menzel, Stephan, et al.
Publicado: (2018)

Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
por: Nobili, Paola, et al.
Publicado: (2022)

Signaling of the Purinergic System in the Joint
por: Corciulo, Carmen, et al.
Publicado: (2020)

Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”
por: Ciruela, Francisco, et al.
Publicado: (2021)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Purinergic Signaling in Mast Cell Degranulation and Asthma
por: Gao, Zhan-Guo, et al.
Publicado: (2017)

Emerging roles of purinergic signaling in anti-cancer therapy resistance
por: Zanoni, Michele, et al.
Publicado: (2022)

Purinergic Signaling in Bone
por: Jørgensen, Niklas Rye, et al.
Publicado: (2013)

Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity
por: Koupenova, Milka, et al.
Publicado: (2018)

Editorial: purinergic signalling—perspectives from Australia and New Zealand
por: Sluyter, Ronald, et al.
Publicado: (2022)

Editorial: Neuroinflammation and Its Resolution: From Molecular Mechanisms to Therapeutic Perspectives
por: Zusso, Morena, et al.
Publicado: (2020)

Targeting Purinergic Signaling in the Dynamics of Disease Progression in Sepsis
por: Leite-Aguiar, Raíssa, et al.
Publicado: (2021)

Editorial: Purinergic Signaling and Inflammation
por: Yuan, Xiaoyi, et al.
Publicado: (2021)

Metabolic Changes Induced by Purinergic Signaling: Role in Food Intake
por: Caruso, Vanni, et al.
Publicado: (2021)

Purinergic signaling: A gatekeeper of blood-brain barrier permeation
por: Wang, Yuemei, et al.
Publicado: (2023)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
por: Dal Ben, Diego, et al.
Publicado: (2018)

Editorial: Emerging perspectives in sodium channelopathies
por: Groome, J. R., et al.
Publicado: (2022)

Editorial: Purinergic Signaling in Health and Disease
por: Boué-Grabot, Eric, et al.
Publicado: (2020)

Use of Humanized Mouse Models to Investigate the Roles of Purinergic Signaling in Inflammation and Immunity
por: Sluyter, Ronald, et al.
Publicado: (2020)

Editorial: Receptor Biology and Cell Signaling in Diabetes
por: Srivastava, Swayam Prakash, et al.
Publicado: (2022)

Elevated Pressure Changes the Purinergic System of Microglial Cells
por: Rodrigues-Neves, Ana C., et al.
Publicado: (2018)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
por: Cieślak, M., et al.
Publicado: (2018)

Editorial: Emerging mechanisms in cardiovascular disease
por: Yalcin, Huseyin C., et al.
Publicado: (2023)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

Erythrocytes Induce Endothelial Injury in Type 2 Diabetes Through Alteration of Vascular Purinergic Signaling
por: Mahdi, Ali, et al.
Publicado: (2020)

P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
por: Lara, Romain, et al.
Publicado: (2020)

Purinergic signaling in the modulation of redox biology
por: Savio, Luiz Eduardo Baggio, et al.
Publicado: (2021)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation
por: Di Liberto, Valentina, et al.
Publicado: (2016)

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
por: Kong, Qihang, et al.
Publicado: (2021)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_es7frpnv4tkjmuoqu6hkm6jq67